Archive for the ‘life extension’ category: Page 470
Aug 25, 2017
This Bio-Hacking Anti-Aging Product Has a Unique Cult Following: Doctors
Posted by Shailesh Prasad in categories: bioengineering, biotech/medical, life extension
Aug 25, 2017
How BioViva Uses Genetic Therapies to Fight Father Time
Posted by Montie Adkins in categories: genetics, life extension
Good quick interview. Technical, and a mention that it’s not just about telomeres.
BioViva is looking for a way to slow aging. Globalive Chairman Anthony Lacavera talks to CEO Elizabeth Parrish, who is using herself as a test subject and claims to have seen some fascinating results. (Source: Bloomberg)
Aug 25, 2017
Can Science Reverse Aging?
Posted by Dan Kummer in categories: engineering, life extension, policy, robotics/AI, science, singularity
Futurist José Cordeiro talks longevity, AI, and the humanitarian crisis in Venezuela.
—————
Aug 23, 2017
Autophagy and How it Aids Longevity
Posted by Steve Hill in categories: biotech/medical, life extension
Autophagy means “eating of self” (“auto”= self; “phag” = eating)[1]. Although its name might sound harmful, autophagy appears to have longevity-promoting effects[2]. Here, we will explain what autophagy is, how it works, its benefits, and how it plays a role in aging.
What is Autophagy?
Autophagy is the way cells break down misbehaving or nonfunctional organelles and proteins in the cell[1,2]. This means autophagy can consume organelles such as, mitochondria, peroxisomes, and the endoplasmic reticulum[1].
Aug 23, 2017
Antoxerene closes $1.5M for drug discovery in aging
Posted by Steve Hill in categories: biotech/medical, life extension
Antoxerene performs pipeline testing for small molecule drugs that target protein-drug and protein-protein interactions. The platform is based on a patent-pending production technology, which enables manufacturing of impossible to express protein targets in biologically active form, at scale.
Aug 23, 2017
Introducing Rejuvenaction Italia and other news
Posted by Nicola Bagalà in categories: biotech/medical, life extension
The Italian version of Rejuvenaction is up and running! If you know Italian speakers who would like to know about rejuvenation biotechnologies and advocacy, please let them know!
I’m pleased to announce the launch of Rejuvenaction Italia, the Italian version of Rejuvenaction. As you might know, Italian is my native language, and while I have neglected/postponed online advocacy in Italian for over two years now, I realised that, as the topic of rejuvenation starts to reach broader audiences, there’s a necessity to make information available in several languages, for the benefit of those who don’t speak English. Regardless of one’s native language, the questions people have about rejuvenation are always the same: How do you do it? Why? Have you thought of overpopulation? And tyrants living forever? and so on. Thus, Rejuvenaction Italia (henceforth officially nicknamed RJi, and accordingly Rejuvenaction will be simply RJ) is essentially a clone of RJ, except in Italian. The blog won’t be nearly as lively as that here on RJ because, you know, there are only 24 hours in a day. I will translate some of the most substantial posts or important news from RJ to RJi, though, and there will be RJi -specific posts that won’t be worth translating into English.
If you speak Italian and/or know someone who does, it may be worth checking out RJ’s Italian clone and share the news on your social media. I would appreciate that very much. 🙂 There’s a link to RJi at the top of the sidebar.
Continue reading “Introducing Rejuvenaction Italia and other news” »
Aug 22, 2017
Regenerative Medicine Market to Reach $5.5 Billion by 2025: Increased Prevalence of Neurodegenerative, Orthopedic & Other Aging-related Disorders
Posted by Dan Kummer in categories: biotech/medical, life extension
DUBLIN, August 21, 2017 /PRNewswire/.
The “Regenerative Medicine Market, 2014 — 2025” report has been added to Research and Markets’ offering.
The global regenerative medicine market size is expected to reach USD 5.59 billion by 2025, according to this new report. Increased prevalence of neurodegenerative, orthopedic, and other aging-related disorders in geriatric population coupled with rising global geriatric population is anticipated to drive market growth.
Aug 22, 2017
FLOW OF WISDOM Interview w/ Zoltan Istvan founder of the Transhumanist Party HR1
Posted by Zoltan Istvan in categories: biotech/medical, cryonics, geopolitics, life extension, robotics/AI, transhumanism
The original date of this broadcast was on August 20, 2017. Zoltan Istvan is the creator of the Transhumanist political party.
Subjects discussed: Cryonics, The merging of machines and humans, advance technology, transhumanism, CRISPR and Artificial Intelligence.
Listen to Flow of Wisdom Radio Live Sundays 3 — 5:00 PM EST on a radio station near you! Also, streaming live on GCNLive.com Call in 877−300−7645. http://flowofwisdom.com
Aug 21, 2017
With Immortality On The Horizon, Will Humanity Be Able To Survive The Technological Transition?
Posted by Klaus Baldauf in categories: biotech/medical, life extension, robotics/AI
Mimetic Evolution or the collective will of humanity to imitate the most successful achievements of nature with technology, has finally set in. At this dawn of artificial intelligence humanity is trying to not only find its place again, but to do the inevitable, the inescapable – merging with the technology we created. We have to be the artificial intelligence by incorporating the transcendent aspects of an artificiality that otherwise could easily become a mastermind, both in control of us and out of control.
Yes, it will begin slowly with AI helping us to achieve dreams of humanity, ways for us to live longer and healthier. Just ask what the many biotech companies focus on and the answer unanimously will be putting an end to aging.
The idea of eternal youth and immortality is a blessing, albeit a mixed one. We learned that progress never stops and it isn’t plausible to think that we now revert back and suddenly stop working on machine learning and connected devices as well as connected thinking.